Iniuva

***We are iniuva.*** We are a team of medical professionals, scientists and forward-thinking experts dedicated to our patients. In the dynamic landscape of pharmaceutical development, iniuva offers a groundbreaking proprietary platform for small molecule drug discovery with a focus on protein misfolding. We firmly believe that each patient counts. We fight misfolding. ***Our AI-powered platform speeds up and significantly improves the path from candidate identification to clinical approval.*** iniuva revolutionizes drug development with an AI-powered discovery platform. We target protein misfolding, a key mechanism in hundreds of rare diseases, offering unmatched scalability. By integrating AI across the value chain, our feedback-driven process sets a new industry standard in model precision. We cut development times from years to months and elevate drug quality and cost-efficiency. This enables rapid delivery of approved therapeutic products to both customers and patients. *** Innovative Rare Disease Solutions for Pharma and Biotech*** We develop small-molecule therapies for rare diseases from the discovery phase to approval. Our clients, including biotech and pharmaceutical companies, engage with us to diversify their portfolios or enter the orphan drug market. They have the flexibility to acquire or license our therapeutic breakthroughs post-approval or collaborate with us at any stage of product development. We provide versatile solutions to drive innovation.